ASPIRO PHARMA LIMITED

ASPIRO PHARMA LIMITED is a Manufacturer (Factory).

Enterprise Introduction:

ASPIRO PHARMA LIMITED is a pharmaceutical company based in India, primarily engaged in the research, development, manufacturing, and marketing of a diverse portfolio of pharmaceutical products. The company operates as a dedicated manufacturer, possessing advanced, state-of-the-art production facilities that comply with stringent international regulatory standards, including WHO-GMP, USFDA, and EU-GMP. Aspiro Pharma specializes in producing various dosage forms, often including sterile injectables, oral solids, and other specialized formulations, catering to both domestic and international markets. Their commitment lies in delivering high-quality, affordable, and accessible medicines, focusing on therapeutic areas that address unmet medical needs. The company's operations encompass the entire pharmaceutical value chain, from active pharmaceutical ingredient (API) sourcing and formulation development to commercial manufacturing and global distribution.

ASPIRO PHARMA LIMITED manufactures or sells products primarily in the following therapeutic and dosage form categories:

Oncology Injectables

These include a wide range of anti-cancer drugs provided in injectable forms.

Examples of active pharmaceutical ingredients in their portfolio include Paclitaxel, Docetaxel, Pemetrexed, Oxaliplatin, Carboplatin, Cyclophosphamide, Doxorubicin, Gemcitabine, Bortezomib, Etoposide, and Irinotecan.

Critical Care Injectables

Products designed for life-threatening conditions and intensive care settings.

This category often includes various antibiotics such as Meropenem, Piperacillin and Tazobactam, Ceftriaxone, and antifungals like Voriconazole.

General Injectables

A diverse portfolio of injectable formulations addressing various therapeutic areas beyond oncology and critical care.

These can include products for pain management, cardiovascular support, central nervous system disorders, and nutritional supplements.